NEU 3.50% $14.05 neuren pharmaceuticals limited

Acadia, page-288

  1. 5,797 Posts.
    lightbulb Created with Sketch. 736
    “The launch of DAYBUE has been one of the most successful recent launches in rare disease

    A flop by Culper standards….


 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.